{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:13:11Z","timestamp":1782947591488,"version":"3.54.5"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R24HD042854"],"award-info":[{"award-number":["R24HD042854"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34DA045619-02"],"award-info":[{"award-number":["R34DA045619-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.drugalcdep.2020.108218","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T18:04:59Z","timestamp":1596391499000},"page":"108218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["ART uptake and adherence among women who use drugs globally: A scoping review"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-1983","authenticated-orcid":false,"given":"Jennifer L.","family":"Glick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rienna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Jivapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayasundaram","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Rosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Pelaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine H.A.","family":"Footer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1353\/hpu.0.0039","article-title":"Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey","volume":"19","author":"Abatemarco","year":"2008","journal-title":"J. Health Care Poor Underserved"},{"issue":"9738","key":"10.1016\/j.drugalcdep.2020.108218_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00042560-200109010-00008","article-title":"Trust and the acceptance of and adherence to antiretroviral therapy","volume":"28","author":"Altice","year":"2001","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0020","series-title":"Women Who Inject Drugs: a Review of Their Risks, Experiences and Needs","author":"Anna Roberts","year":"2010"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10461-008-9441-x","article-title":"Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV\/AIDS, psychiatric and substance-related disorder","volume":"13","author":"Applebaum","year":"2009","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users","volume":"17","author":"Arnsten","year":"2002","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/105504901750160501","article-title":"Predictors of nonadherence to HIV-related medication regimens during methadone stabilization","volume":"10","author":"Avants","year":"2001","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","article-title":"Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis","volume":"15","author":"Azar","year":"2015","journal-title":"BMC infectious diseases ."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0050","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","article-title":"Women, drugs and HIV","volume":"26","author":"Azim","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12879-015-1255-7","article-title":"Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study","volume":"15","author":"Bach","year":"2015","journal-title":"BMC infectious diseases ."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3851\/IMP1849","article-title":"Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe","volume":"16","author":"Bailey","year":"2011","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1186\/1471-2458-14-993","article-title":"Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine","volume":"14","author":"Bailey","year":"2014","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-13-482","article-title":"Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics","volume":"13","author":"Baral","year":"2013","journal-title":"BMC Public Health"},{"issue":"18","key":"10.1016\/j.drugalcdep.2020.108218_bib0075","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1097\/01.aids.0000182518.84407.32","article-title":"Clinical management of depression and anxiety in HIV-infected adults","volume":"19","author":"Basu","year":"2005","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/tcmj.tcmj_177_18","article-title":"Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings","volume":"31","author":"Basu","year":"2019","journal-title":"Tzu-Chi Med. J."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","article-title":"Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions","volume":"19","author":"Bazzi","year":"2019","journal-title":"BMC Public Health"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2020.108218_bib0090","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","article-title":"Practical and conceptual challenges in measuring antiretroviral adherence","volume":"43","author":"Berg","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108218_bib0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1525-1497.2004.30445.x","article-title":"Gender differences in factors associated with adherence to antiretroviral therapy","volume":"19","author":"Berg","year":"2004","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2105\/AJPH.2005.061929","article-title":"Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV\/AIDS","volume":"96","author":"Burke-Miller","year":"2006","journal-title":"Am. J. Public Health"},{"issue":"Suppl 3","key":"10.1016\/j.drugalcdep.2020.108218_bib0105","first-page":"S149","article-title":"2002. Nonadherence among HIV-infected injecting drug users: the impact of social instability","volume":"31","author":"Bouhnik","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0110","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/QAI.0b013e3181baeec2","article-title":"Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV\/AIDS country reports","volume":"52","author":"Carael","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2458-7-271","article-title":"HIV risk behaviors among female IDUs in developing and transitional countries","volume":"7","author":"Cleland","year":"2007","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/COH.0b013e32834f5cf2","article-title":"HIV treatment as prevention and HPTN 052","volume":"7","author":"Cohen","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/09540120500159284","article-title":"Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women","volume":"18","author":"Cook","year":"2006","journal-title":"AIDS Care"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugalcdep.2006.12.002","article-title":"Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women","volume":"89","author":"Cook","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/08897077.2011.540466","article-title":"Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users","volume":"32","author":"Copenhaver","year":"2011","journal-title":"Subst. Abus."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/apc.2013.0329","article-title":"Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States","volume":"28","author":"Dale","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0145","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","article-title":"HIV and the criminalisation of drug use among people who inject drugs: a systematic review","volume":"4","author":"DeBeck","year":"2017","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0150","first-page":"283","article-title":"The relationship of HIV treatment acceptance and adherence to psychosocial factors among injecting drug users","volume":"2","author":"Demas","year":"1998","journal-title":"AIDS Behav."},{"issue":"1\u20132","key":"10.1016\/j.drugalcdep.2020.108218_bib0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2011.12.020","article-title":"Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas","volume":"124","author":"Des Jarlais","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0160","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/QAI.0000000000000622","article-title":"HIV reduction among women who inject drugs can be achieved through women-specific programs and global targets: a model from Ukraine","volume":"69","author":"Deshko","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/COH.0000000000000035","article-title":"Drug use as a driver of HIV risks: re-emerging and emerging issues","volume":"9","author":"El-Bassel","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0170","doi-asserted-by":"crossref","first-page":"e4165","DOI":"10.7717\/peerj.4165","article-title":"CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis","volume":"5","author":"Ellis","year":"2017","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QAI.0000000000001158","article-title":"Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial","volume":"74","author":"Eshleman","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09540121.2011.592821","article-title":"Predictive factors of antiretroviral treatment <4 weeks among HIV-infected pregnant women in Cayenne, French Guiana","volume":"24","author":"Elenga","year":"2012","journal-title":"AIDS care ."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0185","article-title":"CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE","volume":"9","author":"EuroCoord, O.I.P.T.o.t.C.o.O.H.E.R.i.E.i","year":"2012","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drugalcdep.2010.04.017","article-title":"A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention","volume":"111","author":"Feaster","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0195","first-page":"692","article-title":"Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/","volume":"21","author":"Friedman","year":"2009","journal-title":"HIV ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0200","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10461-016-1413-y","article-title":"Social network strategies to address HIV prevention and treatment continuum of care among at-risk and HIV-infected substance users: a systematic scoping review","volume":"21","author":"Ghosh","year":"2017","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0205","first-page":"1","article-title":"The PrEP care continuum among cisgender women who sell sex and\/or use drugs globally: a systematic review","author":"Glick","year":"2019","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0210","series-title":"ART Uptake and Adherence among Female Sex Workers (FSW) Globally: a Scoping Review","author":"Glick","year":"2020"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0215","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10461-013-0674-y","article-title":"Depressive symptoms and antiretroviral therapy (ART) initiation among HIV-infected Russian drinkers","volume":"18","author":"Goodness","year":"2014","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13722-017-0088-7","article-title":"Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV\/AIDS: perspectives of HIV surveillance experts and service providers","volume":"12","author":"Grau","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0225","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25470","article-title":"Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90\u201090\u201090 in sub\u2010Saharan Africa\u2013a systematic review and meta\u2010analysis","volume":"23","author":"Green","year":"2020","journal-title":"J. Int. AIDS Soc."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.socscimed.2004.12.001","article-title":"Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review","volume":"61","author":"Greenhalgh","year":"2005","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10461-012-0319-6","article-title":"Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment","volume":"17","author":"Gonzalez","year":"2013","journal-title":"AIDS and behavior ."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0240","doi-asserted-by":"crossref","first-page":"e4445","DOI":"10.1371\/journal.pone.0004445","article-title":"Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996\u20132004","volume":"4","author":"Grigoryan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fpubh.2016.00062","article-title":"Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study","volume":"4","author":"Gwadz","year":"2016","journal-title":"Front. Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1525-1497.2003.10801.x","article-title":"Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy","volume":"18","author":"Gebo","year":"2003","journal-title":"Journal of General Internal Medicine"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108218_bib0255","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.annepidem.2006.01.009","article-title":"Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001","volume":"16","author":"Hall","year":"2006","journal-title":"Ann. Epidemiol."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0260","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/cid\/cit003","article-title":"Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009","volume":"56","author":"Hanna","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"16","key":"10.1016\/j.drugalcdep.2020.108218_bib0265","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00002030-200211080-00010","article-title":"A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women","volume":"16","author":"Howard","year":"2002","journal-title":"AIDS (London England)"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12879-016-1749-y","article-title":"Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study","volume":"16","author":"Hayashi","year":"2016","journal-title":"BMC infectious diseases ."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0275","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/add.13798","article-title":"Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla\u2010J\u00e4rve, Estonia","volume":"112","author":"Heimer","year":"2017","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/09540120500100882","article-title":"Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial","volume":"17","author":"Haug","year":"2005","journal-title":"AIDS care ."},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2020.108218_bib0285","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.1097\/QAI.0000000000001416","article-title":"Antiretroviral therapy use among HIV-infected people who inject Drugs-20 cities, United States, 2009\u20132015","volume":"75","author":"Hoots","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13691050802431314","article-title":"Sex work in Mexico: vulnerability of male, travesti, transgender and transsexual sex workers","volume":"11","author":"Infante","year":"2009","journal-title":"Cult. Health Sex."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10461-015-1028-8","article-title":"Providing ART to HIV seropositive persons who use drugs: progress in New York City, prospects for \u201cEnding the Epidemic\u201d","volume":"20","author":"Jarlais","year":"2016","journal-title":"AIDS Behav."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108218_bib0300","first-page":"1128","article-title":"Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/","volume":"27","author":"Joseph","year":"2015","journal-title":"HIV ."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108218_bib0305","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/09540120701842746","article-title":"Gender differences in health status and care among HIV-infected minority drug users","volume":"20","author":"Kang","year":"2008","journal-title":"AIDS Care"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108218_bib0310","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/09540121.2011.565022","article-title":"Differential gender effects of depression on use of HIV medications among HIV-positive Puerto Rican drug users","volume":"23","author":"Kang","year":"2011","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0315","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/QAI.0000000000000776","article-title":"2015. Intentional Medication Nonadherence Because of Interactive Toxicity Beliefs Among HIV-Positive Active Drug Users","volume":"70","author":"Kalichman","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0320","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11606-012-2231-1","article-title":"Intentional Non-Adherence to Medications among HIV Positive Alcohol Drinkers: Prospective Study of Interactive Toxicity Beliefs","volume":"28","author":"Kalichman","year":"2013","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0325","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QAI.0b013e318198a800","article-title":"Nonstructured treatment interruptions among injection drug users in Baltimore, MD","volume":"50","author":"Kavasery","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0330","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/09540121.2016.1259451","article-title":"\u201cIt is easier for me to shoot up\u201d: stigma, abandonment, and why HIV-positive drug users in Russia fail to link to HIV care","volume":"29","author":"Kiriazova","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0335","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2334-11-292","article-title":"Five-year trends in epidemiology and prevention of mother-to-child HIV transmission, St. Petersburg, Russia: results from perinatal HIV surveillance","volume":"11","author":"Kissin","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0340","first-page":"43","article-title":"Measurements of medication adherence: in search of a gold standard","volume":"2","author":"Kreys","year":"2016","journal-title":"J. Clin. Pathw."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0345","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/apc.2012.0013","article-title":"Antiretroviral adherence during pregnancy and postpartum in Latin America","volume":"26","author":"Kreitchmann","year":"2012","journal-title":"Aids Patient Care and STDS"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0350","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3851\/IMP1614","article-title":"Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting","volume":"15","author":"Krusi","year":"2010","journal-title":"Antiviral therapy ."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0355","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/09540120701294245","article-title":"Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems","volume":"19","author":"Kim","year":"2007","journal-title":"AIDS care ."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2020.108218_bib0360","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.4103\/0019-5545.161491","article-title":"Substance use in women: current status and future directions","volume":"57","author":"Lal","year":"2015","journal-title":"Indian J. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2020.108218_bib0365","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1097\/QAI.0000000000000623","article-title":"Global epidemiology of HIV among women and girls who use or inject drugs: current knowledge and limitations of existing data","volume":"69","author":"Larney","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","article-title":"Assessing medication adherence: options to consider","volume":"36","author":"Lehmann","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0375","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2105\/AJPH.2008.158949","article-title":"Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005","volume":"100","author":"Lillie-Blanton","year":"2010","journal-title":"Am. J. Public Health"},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108218_bib0380","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-134-10-200105150-00011","article-title":"A comparison study of multiple measures of adherence to HIV protease inhibitors","volume":"134","author":"Liu","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0385","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10461-005-9041-y","article-title":"Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse","volume":"10","author":"Liu","year":"2006","journal-title":"AIDS Behav."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0390","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3844\/ajidsp.2007.240.247","article-title":"HIV medication adherence and substance use: the smartest women\u2019s project","volume":"3","author":"Lopez","year":"2007","journal-title":"Am. J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0395","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0400","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1007\/s10461-017-1818-2","article-title":"The socio-ecological model approach to understanding barriers and facilitators to the accessing of health services by sex workers: a systematic review","volume":"21","author":"Ma","year":"2017","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0405","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugpo.2018.11.004","article-title":"\u201cSomeone who is in this thing that I am suffering from\u201d: the role of peers and other facilitators for task sharing substance use treatment in South African HIV care","volume":"70","author":"Magidson","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0410","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/QAI.0000000000000621","article-title":"What interventions are needed for women and girls who use drugs? A global perspective","volume":"69","author":"Malinowska-Sempruch","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0415","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","article-title":"Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review","volume":"103","author":"Malta","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0420","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12889-018-5291-2","article-title":"Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the seek, test, treat, and retain data harmonization initiative (STTR)","volume":"18","author":"Matsuzaki","year":"2018","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0425","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09540120802001705","article-title":"Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders","volume":"21","author":"Mellins","year":"2009","journal-title":"AIDS care ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0430","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Educ. Q."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0435","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/1354850021000015267","article-title":"Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers","volume":"7","author":"Mellins","year":"2002","journal-title":"Psychol. Health Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0440","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/108729103322277420","article-title":"Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease","volume":"17","author":"Mellins","year":"2003","journal-title":"AIDS Patient Care STDS"},{"issue":"0 2","key":"10.1016\/j.drugalcdep.2020.108218_bib0445","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1097\/QAI.0000000000000660","article-title":"HIV testing, care, and treatment among women who use drugs from a global perspective: progress and challenges","volume":"69","author":"Metsch","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"10149","key":"10.1016\/j.drugalcdep.2020.108218_bib0450","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31487-9","article-title":"A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study","volume":"392","author":"Miller","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0455","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/apc.2011.0169","article-title":"Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting","volume":"26","author":"Milloy","year":"2012","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0460","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10461-014-0890-0","article-title":"Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users","volume":"19","author":"Mizuno","year":"2015","journal-title":"AIDS Behav."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108218_bib0465","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-1293.2012.01021.x","article-title":"Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users","volume":"13","author":"Mann","year":"2012","journal-title":"HIV medicine ."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108218_bib0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105645","article-title":"Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis","volume":"9","author":"Mountain","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0475","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00002030-200001280-00010","article-title":"Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group","volume":"14","author":"Moatti","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jwh.2010.2043","article-title":"Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival","volume":"20","author":"Neblett","year":"2011","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0485","series-title":"Women Who Inject Drugs and HIV: Addressing Specific Needs","author":"Organization","year":"2014"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0490","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/135965350300800601","article-title":"Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme","volume":"8","author":"O'Connell","year":"2003","journal-title":"Antiviral therapy ."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0495","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1022517608578","article-title":"A qualitative investigation of antiretroviral therapy among injection drug users","volume":"7","author":"Pach","year":"2003","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0500","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0505","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1360-0443.2003.00670.x","article-title":"Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment","volume":"99","author":"Palepu","year":"2004","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0510","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11524-011-9562-9","article-title":"Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users","volume":"88","author":"Palepu","year":"2011","journal-title":"J. Urban Health"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int. J. Evid. Healthc."},{"issue":"31","key":"10.1016\/j.drugalcdep.2020.108218_bib0520","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0968-8080(08)31345-7","article-title":"Women, harm reduction and HIV","volume":"16","author":"Pinkham","year":"2008","journal-title":"Reprod. Health Matters"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0525","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/0954012031000068380","article-title":"Qualitative and quantitative assessments of HAART adherence of substance-abusing women","volume":"15","author":"Powell-Cope","year":"2003","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0530","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/QAD.0000000000001408","article-title":"The adherence gap: a longitudinal examination of men\u2019s and women\u2019s antiretroviral therapy adherence in British Columbia, 2000-2014","volume":"31","author":"Puskas","year":"2017","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0535","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10461-013-0584-z","article-title":"Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users","volume":"18","author":"Reddon","year":"2014","journal-title":"AIDS and behavior ."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0540","series-title":"A Report Prepared on Behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use","article-title":"Women who inject drugs: a review of their risks, experiences and needs","author":"Roberts","year":"2010"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0545","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10461-011-0124-7","article-title":"Association between use of specific drugs and antiretroviral adherence: findings from MACH 14","volume":"17","author":"Rosen","year":"2013","journal-title":"AIDS and behavior ."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108218_bib0550","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/09540120412331290176","article-title":"Use of antiretroviral therapy among HIV positive individuals living in British Columbia","volume":"16","author":"Rusch","year":"2004","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0555","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11904-016-0337-5","article-title":"Trauma-informed HIV prevention and treatment","volume":"13","author":"Sales","year":"2016","journal-title":"Curr. HIVAIDS Rep."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0560","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS","volume":"60","author":"Sambamoorthi","year":"2000","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0565","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1013190907847","article-title":"Social factors related to antiretroviral therapy use in injection drug users","volume":"5","author":"Schroeder","year":"2001","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0570","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/B:JOHE.0000016716.99847.9b","article-title":"Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women","volume":"29","author":"Sharpe","year":"2004","journal-title":"J. Commun. Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0575","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10461-014-0847-3","article-title":"High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting","volume":"19","author":"Slawson","year":"2015","journal-title":"AIDS and behavior ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0580","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.ALC.0000122103.74491.78","article-title":"Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems","volume":"28","author":"Samet","year":"2004","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0585","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/cid\/ciu324","article-title":"Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India","volume":"59","author":"Solomon","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108218_bib0590","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2105\/AJPH.2012.301092","article-title":"Antiretroviral medication diversion among HIV-positive substance abusers in South Florida","volume":"103","author":"Surratt","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0595","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2105\/AJPH.2015.302612","article-title":"Environmental influences on HIV medication adherence: the role of neighborhood disorder","volume":"105","author":"Surratt","year":"2015","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0600","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/ADA-100100600","article-title":"Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use","volume":"26","author":"Stein","year":"2000","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1300\/J069v19n01_07","article-title":"Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance","volume":"19","author":"Stein","year":"2000","journal-title":"Journal of Addictive Diseases"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0610","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/apc.2012.0322","article-title":"Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV\/AIDS in the rural South","volume":"27","author":"Tucker","year":"2013","journal-title":"Aids Patient Care and STDS"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0615","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/01.qai.0000230321.85911.db","article-title":"Highly Active Antiretroviral Therapy Interruption: Predictors and Virologic and Immunologic Consequences. JAIDS","volume":"42","author":"Touloumi","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0620","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2334-11-86","article-title":"Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare","volume":"11","author":"Tapp","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0625","article-title":"Intimate partner violence (IPV) against HIV-positive women in Sub-Saharan Africa: a mixed-method systematic review and meta-analysis","author":"Tenkorang","year":"2020","journal-title":"Trauma Violence Abuse"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108218_bib0630","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10461-006-9159-6","article-title":"Alcohol consumption, art usage and high-risk sex among women infected with HIV","volume":"11","author":"Theall","year":"2007","journal-title":"AIDS Behav."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108218_bib0635","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0640","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10461-014-0969-7","article-title":"Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations","volume":"19","author":"Tsuyuki","year":"2015","journal-title":"AIDS Behav."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108218_bib0645","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00005650-200009000-00005","article-title":"Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women","volume":"38","author":"Turner","year":"2000","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0650","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1525-1497.2003.20122.x","article-title":"Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users","volume":"18","author":"Turner","year":"2003","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0655","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1055-3290(06)60241-0","article-title":"Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus","volume":"13","author":"Tedaldi","year":"2002","journal-title":"The Journal of the Association of Nurses in AIDS Care"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0660","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0665","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/157016210794088272","article-title":"Use of highly active antiretroviral therapy is increasing in HIV positive severe drug users","volume":"8","author":"Vallecillo","year":"2010","journal-title":"Curr. HIV Res."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0670","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s10461-015-1211-y","article-title":"Low non-structured antiretroviral therapy interruptions in HIV-infected persons who inject drugs receiving multidisciplinary comprehensive HIV care at an outpatient drug abuse treatment center","volume":"20","author":"Vallecillo","year":"2016","journal-title":"AIDS Behav."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0675","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0680","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10461-005-9062-6","article-title":"Neurocognitive aspects of medication adherence in HIV-positive injecting drug users","volume":"10","author":"Waldrop-Valverde","year":"2006","journal-title":"AIDS and behavior ."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0685","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jana.2012.05.005","article-title":"Medication-taking self-efficacy and medication adherence among HIV-infected cocaine users","volume":"24","author":"Waldrop-Valverde","year":"2013","journal-title":"The Journal of the Association of Nurses in AIDS Care"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0690","first-page":"143","article-title":"Ante- and postpartum substance abuse treatment and antiretroviral therapy among HIV-infected women on Medicaid","volume":"58","author":"Warner","year":"2003","journal-title":"J. Am. Med. Womens Assoc."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0695","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10461-012-0136-y","article-title":"Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting","volume":"17","author":"Werb","year":"2013","journal-title":"AIDS and behavior"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0700","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11904-012-0131-y","article-title":"Current interventions to reduce sexual risk behaviors and crack cocaine use among HIV-infected individuals","volume":"9","author":"Wechsberg","year":"2012","journal-title":"Curr. HIVAIDS Rep."},{"key":"10.1016\/j.drugalcdep.2020.108218_bib0705","series-title":"Policy Brief: Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations, 2016 Update","author":"WHO","year":"2017"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0710","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1258\/0956462001914797","article-title":"Perceived compliance with AZT dosing among a sample of African-American drug users","volume":"11","author":"Williams","year":"2000","journal-title":"Int. J. STD AIDS"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108218_bib0715","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","article-title":"A proposal for quality standards for measuring medication adherence in research","volume":"17","author":"Williams","year":"2013","journal-title":"AIDS Behav."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108218_bib0720","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/apc.2005.19.326","article-title":"Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users","volume":"19","author":"Waldrop-Valverde","year":"2005","journal-title":"Aids Patient Care and STDS"},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108218_bib0725","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/1087291041518238","article-title":"Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users","volume":"18","author":"Wagner","year":"2004","journal-title":"Aids Patient Care and STDS"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108218_bib0730","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/09540121.2013.873765","article-title":"Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse","volume":"26","author":"Wilson","year":"2014","journal-title":"AIDS Care"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108218_bib0735","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jinf.2005.07.008","article-title":"Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users","volume":"52","author":"Wood","year":"2006","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108218_bib0740","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10461-017-1808-4","article-title":"The impact of substance use on adherence to antiretroviral therapy among HIV-infected women in the United States","volume":"22","author":"Zhang","year":"2018","journal-title":"AIDS Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2020.108218_bib0745","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/add.12782","article-title":"Predictors of accessing antiretroviral therapy among HIV\u2010positive drug users in China\u2019s National Methadone Maintenance Treatment Programme","volume":"110","author":"Zhao","year":"2015","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:59:58Z","timestamp":1778536798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620303835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":149,"alternative-id":["S0376871620303835"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108218","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ART uptake and adherence among women who use drugs globally: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108218"}}